M Altinbas

Erciyes Üniversitesi, Kayseri, Kayseri, Turkey

Are you M Altinbas?

Claim your profile

Publications (13)24.02 Total impact

  • Source
    Article: Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group.
    [show abstract] [hide abstract]
    ABSTRACT: Our objective was to determine whether oral etoposide and cisplatin combination (EoP) is superior to paclitaxel in the treatment of advanced breast cancer (ABC) patients pretreated with anthracyclines. From December 1997 to August 2003, 201 patients were randomised, 100 to EoP and 101 to paclitaxel arms. Four patients in each arm were ineligible. The doses of etoposide and cisplatin were 50 mg p.o. twice a day for 7 days and 70 mg m(-2) intravenously (i.v.) on day 1, respectively, and it was 175 mg m(-2) on day 1 for paclitaxel. Both treatments were repeated every 3 weeks. A median of four cycles of study treatment was given in both arms. The response rate obtained in the EoP arm was significantly higher (36.3 vs 22.2%; P=0.038). Median response duration was longer for the EoP arm (7 vs 4 months) (P=0.132). Also, time to progression was significantly in favour of the EoP arm (5.5 vs 3.9 months; P=0.003). Median overall survival was again significantly longer in the EoP arm (14 vs 9.5 months; P=0.039). Toxicity profile of both groups was similar. Two patients in each arm were lost due to febrile neutropenia. The observed activity and acceptable toxicity of EoP endorses the employment of this combination in the treatment of ABC following anthracyclines.
    British Journal of Cancer 03/2005; 92(4):639-44. · 5.04 Impact Factor
  • Source
    Article: A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.
    [show abstract] [hide abstract]
    ABSTRACT: Small cell lung cancer (SCLC) is a chemotherapy-responsive tumor type but most patients ultimately experience disease progression. SCLC is associated with alterations in the coagulation system. The present randomized clinical trial (RCT) was designed to determine whether addition of low-molecular-weight heparin (LMWH) to combination chemotherapy (CT) would improve SCLC outcome compared with CT alone. Combination CT consisted of cyclophosphamide, epirubicine and vincristine (CEV) given at 3-weekly intervals for six cycles. Eighty-four patients were randomized to receive either CT alone (n = 42) or CT plus LMWH (n = 42). LMWH consisted of dalteparin given at a dose of 5000 U once daily during the 18 weeks of CT. Results Overall tumor response rates were 42.5% with CT alone and 69.2% with CT plus LMWH (P = 0.07). Median progression-free survival was 6.0 months with CT alone and 10.0 months with CT plus LMWH (P = 0.01). Median overall survival was 8.0 months with CT alone and 13.0 months with CT plus LMWH (P = 0.01). Similar improvement in survival with LMWH treatment occurred in patients with both limited and extensive disease stages. The risk of death in the CT + LMWH group relative to that in the CT group was 0.56 (95% confidence interval 0.30, 0.86) (P = 0.012 by log rank test). Toxicity from the experimental treatment was minimal and there were no treatment-related deaths. These results support the concept that anticoagulants, and particularly LMWH, may improve clinical outcomes in SCLC. Further clinical trials of this relatively non-toxic treatment approach are indicated.
    Journal of Thrombosis and Haemostasis 09/2004; 2(8):1266-71. · 5.73 Impact Factor
  • Article: Meropenem +/- granulocyte colony stimulating factor in the treatment of febrile neutropenic patients with cancer: prospective randomized study.
    [show abstract] [hide abstract]
    ABSTRACT: The purpose of this study was to evaluate the impact of granulocyte-colony stimulating factor (G-CSF) on the therapy for febrile neutropenia (FN). Our patient population differed significantly from those of previous studies as no patients received antimicrobial or CSF prophylaxis before randomization and all were solid tumor patients. When the diagnosis of FN was established, patients were started on intravenous meropenem 1 g every 8 hours and randomly assigned to receive G-CSF (5 microg/kg body weight per day subcutaneously) or not. Twenty-eight patients with 30 FN episodes received G-CSF and 25 patients with 30 FN episodes did not receive G-CSF according to randomization. The time to resolution of fever, recovery of neutrophil count over 1000/mm3, duration of hospitalization, need for erythrocyte and platelet transfusion and mortality rate were similar in both study groups. Side effects of therapy were mild. These results provide preliminary evidence that G-CSF administration, in addition to effective antibiotic therapy as treatment of febrile neutropenic patients with solid tumor, does not help improve infection-related morbidity and mortality.
    Journal of chemotherapy (Florence, Italy) 07/2004; 16(3):288-92. · 1.08 Impact Factor
  • Article: Post-operative sequential chemo-radiotherapy in high-grade cerebral gliomas with fotemustine.
    [show abstract] [hide abstract]
    ABSTRACT: High-grade gliomas are the most common primary brain tumors in adults. Twenty-seven patients with histopathologically proven anaplastic astrocytoma and glioblastoma multiforme were enrolled in this study from November 1998 to August 2002. Radiotherapy was administered after surgery and fotemustine (100 mg/m2) was sequentially administered every 3 weeks for 6 cycles. Overall, 111 cycles were administered to the 27 patients (median, 5 cycles; range, 1 to 6 cycles). Myelosuppression was mild to moderate. The median overall survival and progression free survival were 11+/-3.1 months (95%CI, 4.9-17.1) and 8+/-0.5 months (95%CI 7.1-8.9), respectively. One-year and two-year survivals were calculated at 48% and 7%, respectively. Significant prognostic factors (P<0.05) via univariate analysis were divided into two groups: completion of 6 cycles of chemotherapy versus incompletion of 6 cycles of chemotherapy. This trial demonstrates that postoperative radiotherapy and sequential fotemustine therapy is feasible, well tolerated, and may prolong survival in patients with newly diagnosed high-grade gliomas.
    Journal of chemotherapy (Florence, Italy) 06/2004; 16(3):298-302. · 1.08 Impact Factor
  • Article: Effect of high salinity on anaerobic treatment of low strength effluents.
    [show abstract] [hide abstract]
    ABSTRACT: In anaerobic treatment, it is obligatory to know the effect of potentially inhibitory compounds due to the fact that methane formation may retard severely and may proceed slower than organic acid production. One of the most important inhibitory substances in anaerobic treatment is high salinity. In many cases, the main collectors of a municipal sewer system should have been built in the coastal zone and below the ground water level due to the available topography of wastewater catchments area, which is carrying the risk of seawater infiltration. Besides, one of the most convenient methods for leachate control is to treat landfill leachates with domestic wastewaters in the central municipal wastewater treatment plants such as in Istanbul. Thus, the nitrogen load of the treatment plants increase significantly. In this study, the effects of high salinity and ammonium nitrogen levels on mesophilic anaerobic tretament processes were investigated. In the first part of the study, high salinity effect on anaerobic treatment was investigated by feeding synthetic wastewater containing high salinity between 0.15%-1.5% ratios. In the second part of the study, the simultaneous effect of high salinity and ammonia (1.5% salinity+1,000 mg NH3/l) was examined by a lab-scale Upflow Anaerobic Sludge Bed Reactor (UASBR). Results indicated no significant inhibition in both cases and effective COD removals (89%) and total biogas productions having methane content of 84% could be achieved.
    Water Science & Technology 02/2003; 48(11-12):207-12. · 1.12 Impact Factor
  • Article: Ammonia recovery from high strength agro industry effluents.
    M Altinbas, I Ozturk, A F Aydin
    [show abstract] [hide abstract]
    ABSTRACT: The aim of the study was to investigate ammonia recovery from high strength agro industry effluents involving significant amounts of ammonia, by applying magnesium ammonium phosphate (MAP) precipitation technology. Two types of industrial effluents have been tested in the study. The first plant was an opium alkaloid processing industry and the second one was a baker's yeast industry. High chemical oxygen demand (COD), total Kjeldahl nitrogen (TKN) and unacceptable dark brown color characterized effluents from both industries. Effluents from the biologically treated opium alkaloid and baker's yeast industries were both applied at the stoichiometric ratio (Mg:NH4:PO4 = 1:1:1) and above the stoichiometric ratio (Mg:NH4:PO4 = 1.1:1:1.1) to MAP precipitation. NH4 removals of 61-80% were achieved at the pH of 9.2 at the stoichiometric ratio, whereas 83% NH4 removal was obtained at the pH of 9.2 above the stoichiometric ratio. Experimental studies performed on both anaerobically and/or aerobically treated baker's yeast and opium alkaloid industry effluents have clearly indicated that MAP precipitation was an appropriate treatment option for NH4 removal or struvite recovery from high ammonia content agro industry effluents. Additional ammonia recovery studies were conducted on ozonated and Fenton's oxidation applied effluents and these have also indicated that the amounts of struvite and the quality of MAP precipitate was increased significantly. In this framework, MAP sludge recovered from combined biological and Fenton's oxidation treatment effluents were considered as a more valuable slow release fertilizer for agricultural use.
    Water Science & Technology 02/2002; 45(12):189-95. · 1.12 Impact Factor
  • Article: Advanced treatment of high strength opium alkaloid industry effluents.
    [show abstract] [hide abstract]
    ABSTRACT: The purpose of this study was to investigate an effective treatment system which can be applicable to treat opium alkaloid industry (OAI) effluents characterised with high COD, TKN, dark color and non-biodegradable organic pollutants. In the first phase of the study, lab-scale anaerobic (UASBR) + aerobic (SBR) treatability studies were carried out on opium processing industry effluents. Effluent CODs from the two staged biological treatment system were relatively high (-700 mg l(-1)) and additional post treatment was required. Physico-chemical treatability studies previously carried out on the effluent of opium alkaloid wastewater treatment plant, were not effective in removing residual COD and color. In the second phase of the study, the refractory organics causing higher inert COD values in the SBR effluent were additionally treated by using Fenton's Oxidation. The batch tests were performed to determine the optimum operating conditions including pH, H2O2 dosage, molar ratio of Fe2+/H2O2 and reaction time. It was found that removal efficiencies of COD and color for 30 minutes reaction time were about 90% and 95%, respectively. The ratio of H2O2/FeSO4 was determined as 200 mg l(-1)/600 mg l(-1) for the optimum oxidation and coagulation process at pH 4. Experimental results of the present study have clearly indicated that the Fenton's oxidation technology is capable to treat almost all parts of the organics which consist of both soluble initial and microbial inert fractions of COD for opium alkaloid industry effluents. Effluents from the Fenton's Oxidation process can satisfy effluent standards for COD and color in general.
    Water Science & Technology 02/2002; 46(9):323-30. · 1.12 Impact Factor
  • Article: A new process for the combined treatment of municipal wastewaters and landfill leachates in coastal areas.
    C Yangin, S Yilmaz, M Altinbas, I Ozturk
    [show abstract] [hide abstract]
    ABSTRACT: One of the most convenient methods for leachate control is to treat landfill leachates with domestic wastewaters. In this framework, a two-stage treatment system including anaerobic pre-treatment combined with a chemical post-treatment system such as ammonia stripping and/or Magnesium Ammonium Phosphate (MAP) precipitation can be comparable with a conventional secondary biological treatment. In this study, 2.5% and 2% of leachate by volume was mixed with domestic wastewater as the feed for the mesophilic Upflow Anaerobic Sludge Bed Reactor (UASBR). pH, feed strength and hydraulic retention time (HRT) were monitored for the evaluation of the performance of the anaerobic process. The HRT's varied from 0.76 to 0.52 d and 58% and 85% COD removal efficiencies were obtained at Organic Loading Rates (OLR) of 0.63 and 2 kg COD/m3.d respectively. The average biomass (VS) concentration in the reactor increased from 40 g/l to 50 g/l during the study. Effluents from the UASBR were further treated chemically either with lime for ammonia stripping or with MAP precipitation. MAP precipitation was applied both at the stoichiometric ratio (Mg:NH4:PO4 = 1:1:1) and above the stoichiometric ratio (Mg:NH4:PO4 = 1:1:1.3). Maximum NH4 removal of 66% was achieved at the pH of 9.3 at the stoichiometric ratio, whereas 86% NH4 removal was obtained at the pH of 9.3 above the stoichiometric ratio. Alternatively, ammonia stripping was applied either to the effluents directly taken from the anaerobic reactor or to the effluents to which MAP precipitation was applied stoichiometrically. Ammonia stripping was conducted for 24 h and 89% NH4 removal was observed at the end of 24 h. Consequently, this study indicates that anaerobic pre-treatment combined with chemical post-treatment (MAP) produced high quality of effluent comparable to the conventional biological treatment especially in terms of N and P levels.
    Water Science & Technology 02/2002; 46(8):111-8. · 1.12 Impact Factor
  • Article: Effects of DMSO on platelet functions and P-selectin expression during storage.
    [show abstract] [hide abstract]
    ABSTRACT: Recent studies suggested that the expression of P-Selectin on stored platelets is related to in vitro activation and loss of viability. We examined the effects of dimethylsulfoxide (DMSO) on in vitro function and P-Selectin expression of platelet concentrates. Fresh random-donor platelet units (n = 60) were divided into four equal groups. A DMSO-free group was chosen as a control. DMSO (0.5%, 1.0%, and 3.0%) was added to the other three groups. The samples were stored on a horizontal shaker at room temperature. Biochemical, morphological and platelet function tests and P-Selectin expression were monitored during storage. In all groups, P-Selectin expression, lactate and LDH levels, mean platelet volumes and PO2 increased but the aggregation response to agonist, the recovery response to hypotonic shock, platelet count, glucose level, pCO2, and HCO3 decreased during storage. In DMSO-containing groups, the P-Selectin expression which is a predictor of in vitro activation, was found significantly less often than in the DMSO-free group.
    Transfusion and Apheresis Science 07/2001; 24(3):261-7. · 1.25 Impact Factor
  • Article: Facial nerve paralysis and paraplegia as presenting symptoms of acute myeloid leukemia.
    [show abstract] [hide abstract]
    ABSTRACT: Granulocytic sarcoma is an extramedullary tumor associated with acute or chronic leukemias or myeloproliferative disorders. Rarely, the tumor may be seen before the diagnosis of leukemia. Symptomatic facial nerve paralysis and spinal cord invasion by granulocytic sarcomas are also relatively uncommon. We present here a 17-year-old-female patient who had facial nerve paralysis and paraplegia due to granulocytic sarcoma as the presenting symptoms of acute myeloid leukemia.
    Japanese Journal of Clinical Oncology 03/2001; 31(2):86-8. · 1.78 Impact Factor
  • Article: Shedding of the nails due to chemotherapy (onychomadesis)
    M Cetin, S Utas, A Unal, M Altinbas
    Journal of the European Academy of Dermatology and Venereology 10/1998; 11(2):193-4. · 2.98 Impact Factor
  • Article: Solitary plasmacytoma: experiences from Central Anatolia.
    [show abstract] [hide abstract]
    ABSTRACT: Solitary plasmacytoma localised to bone or soft tissue without myeloma. Clinical features and survival was analysed in patients from Central Anatolia. Twenty-three solitary plasmacytoma (18 male, 5 female) were evaluated retrospectively. Median age was 58 years (46-72). The major localisation was vertebral column. All patients but one (larynx) had surgical resection and 21 patients received radiotherapy postoperatively. Multiple myeloma developed in eight patients (35%) and local relapse was detected in one patient. Eight patients died, causes of death were multiple myeloma progression in six patients, local relapse of intracranial plasmacytoma in one patient and cranial trauma in one patient who was in complete remission. Three and 5 years progression free survival were 45.6% and 22.8% respectively and overall survivals were 54.4% and 27.2% respectively. Solitary plasmacytoma cases should be followed carefully regarding local relapse and progression to myeloma.
    Irish Journal of Medical Science 174(1):33-6. · 0.58 Impact Factor
  • Article: Etoposide? Or polysorbate-80?
    A Aksahin, D Colak, M Altinbas
    Indian Journal of Cancer 48(2):272-3.